Shilpa Gupta, MD | Authors

Treatment Options After Progression on Frontline Maintenance Therapy

May 13, 2022

Petros Grivas, MD, PhD, revisits the patient profile and invites panel members to share recommended treatment options for patients with or without FGFR mutations, who progress after chemotherapy and maintenance avelumab.